Cochlear Limited CHEOY
49.10 USD -0.21 (-0.43%)
At closeNov 3, 2026, 4:00 PM EST
49.10 Day range 49.37
31.82 52-week range 98.29
- YTD
- -43.19%
- 1 year
- -46.75%
- Market cap
- 6.42B
- EPS (ttm)
- 0.76
- P/E ratio
- 64.61
- YTD return
- -43.19%
- 1-year return
- -46.75%
- Volume
- 1.77K
- Avg volume
- 19.80K
- Open
- 49.36
- Previous close
- 49.31
- Day's range
- 49.10 – 49.37
- 52-week range
- 31.82 – 98.29
1Y -42.02 (-46.08%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2026 | Dec 31, 2025 | — | 0.811 | — | — |
| Aug 18, 2025 | Jun 30, 2025 | — | 0.915 | — | — |
| Feb 13, 2025 | Dec 30, 2024 | — | 0.967 | — | — |
| Aug 15, 2024 | Jun 30, 2024 | — | 0.839 | — | — |
| Feb 18, 2024 | Dec 31, 2023 | — | 0.992 | — | — |
| Jun 30, 2023 | Jun 30, 2023 | — | 0.80 | — | — |
News
Cochlear Limited (CHEOY) Shareholder/Analyst Call Prepared Remarks Transcript 
CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Stock Now Rated “Hold” by Sell-Side Analysts 
Cochlear to defend shareholder class action over 2026 profit forecast 
Cochlear Reaches More Than 1 Million Hours of Patient Experience Across Its Fully Implantable Hearing Technology Research Program 
Cochlear Limited (CHEOY) Q4 2026 Earnings Call Transcript 
CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Sees Significant Drop in Short Interest 
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant 
Better Hearing and Whole-Body Health: What to Know About MRI Access with Cochlear Implants 
Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant 
MED-EL USA Presents Real World Clinical Insights to Support Tailored Hearing Solutions at the 2026 American Cochlear Implant Association Meeting
Your note
Sign in to keep a note on CHEOY — it syncs with the Stock Master app.